Investigating how hemoglobin alpha affects blood vessel function in diabetes
The role of hemoglobin alpha in diabetes-related vascular dysfunction
This study is looking at how a protein in your red blood cells, called hemoglobin alpha, affects blood vessel problems in people with diabetes, and it aims to find out how sugar changes this protein's function to help improve vascular health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-10886112 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of hemoglobin alpha, a protein in red blood cells, in the vascular dysfunction often seen in diabetes. The study will explore how glycation, a process where sugar molecules attach to proteins, alters the function of hemoglobin alpha in the endothelial cells lining blood vessels. Using both pharmacological and genetic methods, researchers will disrupt the interaction between hemoglobin alpha and a key enzyme involved in blood vessel function, aiming to uncover how these changes contribute to vascular issues in diabetic patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who experience vascular complications.
Not a fit: Patients without diabetes or those who do not have vascular dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies to improve vascular health in diabetic patients.
How similar studies have performed: Previous research has shown that targeting glycation processes in hemoglobin can lead to improved understanding and management of diabetes-related complications.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Bagher, Pooneh — University of Nebraska Medical Center
- Study coordinator: Bagher, Pooneh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.